Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2019-02-15

FDA Approved: CLOBETASOL PROPIONATE — Original Application (Glenmark Pharmaceuticals Inc., USA)

View source ↗

Summary

FDA approves Glenmark's generic clobetasol propionate topical product under an Original Application (ANDA).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • CLOBETASOL PROPIONATE (Clobetasol propionate)

Snippet

ORIG AP for CLOBETASOL PROPIONATE (CLOBETASOL PROPIONATE)